SMi's inaugural ADC Summit will provide attendees with a complete view of the antibody drug conjugate field. Focusing on the current ADC pipeline, ADC design, novel ADC utilities and manufacturing considerations. This informative and exciting event will provide attendees with an indepth look into developing ADCs, taking into account target selection and payload delivery techniques.
The event will present itself as a perfect forum for learning about new advances in the field, presenting attendees with the latest information on technogical and regulatory updates in the field. The ADC Summit 2012 will shed light on a new perpspective of the ADC sector, looking at uses of Antibody-Drug Conjugates in alternative therapies.
With senior industry representatives presenting on their own exepriences and referring to case studies, success stories and failures, this event promises to be a unique forum for problem-solving debate and idea-sharing discussion.